The words we use to describe the drugs used to treat psychiatric disorders are too often anachronistic. They are a hodge podge of chemical, pharmacological and clinical terms. The Neuroscience based Nomenclature (NbN), developed by the leading societies for psychopharmacology (ECNP, ACNP, CINP, AsCNP, IUPHAR) addresses mechanism of action rather than indication or chemistry. It has been developed by consensus over the last decade. It provides a better way for clinicians to think about the drugs they prescribe and is instantiated in an app available for use on mobile devices. The session will review the development of NbN, its immediate advantages and its potential to improve education, training and practice.
Chair: Professor Belinda Lennox, University of Oxford
The principles of the Neuroscience based Nomenclature (NbN) - Professor Yossi Zohar, Tel Aviv, Israel
The structure and content of NbN: worked examples of common drug classes - Dr Sue Wilson, Imperial College, London
Putting NbN into practice: mode of action as the message - Professor Guy Goodwin, University of Oxford
